NeuroPace (NPCE) Return on Capital Employed (2021 - 2026)
NeuroPace (NPCE) posted quarterly Return on Capital Employed of 19.47% for Q1 2026, up 250.0% year-over-year from 5.56% in Q1 2025, and down 5.6% quarter-over-quarter from 18.44% in Q4 2025.
NeuroPace (NPCE) Return on Capital Employed (2021 - 2026) Analysis & Trends
NeuroPace's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 19.47% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 250.0% year-over-year to 19.47%; the TTM figure through Mar 2026 stood at 19.47% (up 250.0% YoY), while the FY2025 annual figure was 19.85%, up 535.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 19.47%, down from 18.44% in the prior quarter.
- The five-year high for Return on Capital Employed was 18.44% in Q4 2025, with the low at 39.23% in Q1 2023.
- The 5-year median for Return on Capital Employed is 29.29% (2024), against an average of 29.08%.
- The sharpest annual moves came in 2022 and 2024: Return on Capital Employed slumped 2322 bps in 2022, then surged 994 bps in 2024.
- NeuroPace's Return on Capital Employed stood at 38.37% in 2022, then rose by 19 bps to 31.15% in 2023, then climbed by 13 bps to 26.98% in 2024, then surged by 32 bps to 18.44% in 2025, then dropped by 6 bps to 19.47% in 2026.
- Business Quant data shows NPCE's Return on Capital Employed at 19.47% in Q1 2026, 18.44% in Q4 2025, and 20.93% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | -18.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.73% |
| Mar 31, 2026 | -19.47% |
| Dec 31, 2025 | -18.44% |
| Sep 30, 2025 | -20.93% |
| Jun 30, 2025 | -21.83% |
| Mar 31, 2025 | -21.97% |
| Dec 31, 2024 | -26.98% |
| Sep 30, 2024 | -28.63% |
| Jun 30, 2024 | -29.48% |
| Mar 31, 2024 | -29.29% |
| Dec 31, 2023 | -31.15% |
| Sep 30, 2023 | -36.36% |
| Jun 30, 2023 | -39.07% |
| Mar 31, 2023 | -39.23% |
| Dec 31, 2022 | -38.37% |
| Sep 30, 2022 | -36.29% |
| Jun 30, 2022 | -32.03% |
| Mar 31, 2022 | -24.85% |
| Dec 31, 2021 | -18.53% |
| Sep 30, 2021 | -13.07% |